TITLE

CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF

PUB. DATE
August 2012
SOURCE
Biomedical Market Newsletter;8/15/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information that AIDS Healthcare Foundation (AHF) commented on the new guidance from the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the use of AIDS treatment drug Truvada from Gilead Sciences Inc. as pre-exposure prophylaxis (PrEP) from gay and bisexual men to women and heterosexuals. AHF's concerns are over the health risks of PrEP.
ACCESSION #
80184973

 

Related Articles

  • CDC's Support for Gilead's HIV Prevention Pill for Women is Reckless Says AHF.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article focuses on the new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC) for the expansion of the usage of drugs from Gilead Sciences Inc. It informs that these guidelines are being opposed by AIDS Healthcare Foundation (AHF) due to unavailability of...

  • AHF on CDC Report: "Targeted HIV Testing Could Cut New Infections In Half".  // Biomedical Market Newsletter;6/30/2011, p26 

    The article focuses on the response of the AIDS Healthcare Foundation (AHF) regarding the results of the three-year HIV testing effort of the U.S. Centers for Disease Control and Prevention (CDC) in the U.S. According to AHF, the CDC report further confirm the link between HIV testing, linkage...

  • AHF to Stage "Day of the Dead" Funeral Procession to Protest Gilead's AIDS Drug Prices.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p588 

    The article reports on the funeral procession and protest hosted by AIDS Healthcare Foundation (AHF) against Gilead Sciences Inc.'s pricing of its HIV/AIDS medications in California. It mentions that protesters will honor and remember those who have died of AIDS while on AIDS Drug Assistance...

  • Drug Combo Prevents HIV Infection in Monkeys.  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article reports on a study by Walid Heneine and colleagues at the United States Centers for Disease Control on the effectiveness of Gilead Science's drugs in preventing HIV infections in rhesus monkeys. The drugs are the tenofovir Viread and the emtracitibine Emtriva. The drugs were injected...

  • Truvada prevents HIV infection--now what?  // Advocate;5/9/2006, Issue 962, p21 

    The article reports on the significance of Truvada, a drug used for the treatment of AIDS, to the gay community. The U.S. Centers for Disease Control and Prevention released a study in March 2006 which showed that the drug prevented HIV infection in monkeys. Truvada manufacturer Gilead Sciences...

  • 1 October News.  // Clinical Infectious Diseases;Oct2012, Vol. 55 Issue 7, pi 

    The article offers science news briefs as of October 1, 2012. The U.S. Disease Control and Prevention has recommended for the management of hepatitis B virus (HBV) infected healthcare providers to reduce the risk for transmitting HBV to patients during surgical procedures. Research scientists...

  • AHF Urges Health Plans to Adopt New Routine HIV Testing Recommendation from U.S. Preventative Services Task Force.  // Insurance Broadcasting;5/2/2013, p1 

    The article informs that the organization AIDS Healthcare Foundation (AHF) praised the government agency U.S. Preventive Services Task Force for its recommendation for routine testing for HIV infection. The recommendation comes seven years after the issuance of similar guidelines by the U.S....

  • Corporate New Update.  // PharmaWatch: Biotechnology;Jun2008, Vol. 7 Issue 6, p19 

    The article offers news briefs in the biopharmaceutical industry in the U.S. Gilead Sciences Inc. has appointed Robin Washington as senior vice president and chief financial officer (CFO). Acambis has received a 10-year contract for its ACAM2000 smallpox vaccine from the U.S. Centers for Disease...

  • The Second 100,000. Klitsch, Michael // Family Planning Perspectives;Mar/Apr92, Vol. 24 Issue 2, p50 

    The article reports that the number of AIDS patients in the U.S. doubled in a period of nearly two years. Number of AIDS cases in September 1989 were approximately 100,000 which grew up to more than 200,000 in just November 1991. It was reported by the U.S. Centers for Disease Control that the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics